NLGN4X TCR transgenic T cells to treat gliomas

Background.   Neuroligin 4 X-linked (NLGN4X) harbors a human leukocyte antigen (HLA)-A*02-restricted tumorassociated antigen, overexpressed in human gliomas, that was found to induce specific cytotoxic T cell responses following multi-peptide vaccination in patients with newly diagnosed glioblastoma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krämer, Christopher (VerfasserIn) , Kilian, Michael (VerfasserIn) , Chih, Yu-Chan (VerfasserIn) , Kourtesakis, Alexandros (VerfasserIn) , Hoffmann, Dirk C. (VerfasserIn) , Boschert, Tamara (VerfasserIn) , Koopmann, Philipp (VerfasserIn) , Sanghvi, Khwab (VerfasserIn) , De Roia, Alice (VerfasserIn) , Jung, Stefanie (VerfasserIn) , Jähne, Kristine (VerfasserIn) , Day, Bryan (VerfasserIn) , Shultz, Lenny D. (VerfasserIn) , Ratliff, Miriam (VerfasserIn) , Harbottle, Richard (VerfasserIn) , Green, Edward W. (VerfasserIn) , Will, Rainer (VerfasserIn) , Wick, Wolfgang (VerfasserIn) , Platten, Michael (VerfasserIn) , Bunse, Lukas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2024
In: Neuro-Oncology
Year: 2024, Jahrgang: 26, Heft: 2, Pages: 266-278
ISSN:1523-5866
DOI:10.1093/neuonc/noad172
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/neuonc/noad172
Verlag, kostenfrei, Volltext: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noad172/7275527
Volltext
Verfasserangaben:Christoper Krämer, Michael Kilian, Yu-Chan Chih, Alexandros Kourtesakis, Dirk C Hoffmann, Tamara Boschert, Philipp Koopmann, Khwab Sanghvi, Alice De Roia, Stefanie Jung, Kristine Jähne, Bryan Day, Lenny D Shultz, Miriam Ratliff, Richard Harbottle, Edward W Green, Rainer Will, Wolfgang Wick, Michael Platten, and Lukas Bunse

MARC

LEADER 00000caa a2200000 c 4500
001 1877432997
003 DE-627
005 20260126102253.0
007 cr uuu---uuuuu
008 240108s2024 xx |||||o 00| ||eng c
024 7 |a 10.1093/neuonc/noad172  |2 doi 
035 |a (DE-627)1877432997 
035 |a (DE-599)KXP1877432997 
035 |a (OCoLC)1425207973 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krämer, Christopher  |d 1997-  |e VerfasserIn  |0 (DE-588)1279191635  |0 (DE-627)1832479978  |4 aut 
245 1 0 |a NLGN4X TCR transgenic T cells to treat gliomas  |c Christoper Krämer, Michael Kilian, Yu-Chan Chih, Alexandros Kourtesakis, Dirk C Hoffmann, Tamara Boschert, Philipp Koopmann, Khwab Sanghvi, Alice De Roia, Stefanie Jung, Kristine Jähne, Bryan Day, Lenny D Shultz, Miriam Ratliff, Richard Harbottle, Edward W Green, Rainer Will, Wolfgang Wick, Michael Platten, and Lukas Bunse 
264 1 |c February 2024 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 16. September 2023 
500 |a Gesehen am 08.01.2024 
520 |a Background.   Neuroligin 4 X-linked (NLGN4X) harbors a human leukocyte antigen (HLA)-A*02-restricted tumorassociated antigen, overexpressed in human gliomas, that was found to induce specific cytotoxic T cell responses following multi-peptide vaccination in patients with newly diagnosed glioblastoma. - Methods.   T cell receptor (TCR) discovery was performed using droplet-based single-cell TCR sequencing of NLGN4X-tetramer-sorted T cells postvaccination. The identified TCR was delivered to Jurkat T cells and primary human T cells (NLGN4X-TCR-T). Functional profiling of NLGN4X-TCR-T was performed by flow cytometry and cytotoxicity assays.Therapeutic efficacy of intracerebroventricular NLGN4X-TCR-T was assessed in NOD scid gamma (NSG) major histocompatibility complex (MHC) I/II knockout (KO) (NSG MHC I/II KO) mice bearing NLGN4Xexpressing experimental gliomas. - Results.   An HLA-A*02-restricted vaccine-induced T cell receptor specifically binding NLGN4X131-139 was applied for preclinical therapeutic use. Reactivity, cytotoxicity, and polyfunctionality of this NLGN4X-specificTCR are demonstrated in various cellular models. Intracerebroventricular administration of NLGN4X-TCR-T prolongs survival and leads to an objective response rate of 44.4% in experimental glioma-bearing NSG MHC I/II KO mice compared to 0.0% in control groups. - Conclusion.   NLGN4X-TCR-T demonstrate efficacy in a preclinical glioblastoma model. On a global scale, we provide the first evidence for the therapeutic retrieval of vaccine-induced human TCRs for the off-the-shelf treatment of glioblastoma patients.Keywords cell therapy | glioblastoma | T cell receptor | tumor antigen 
700 1 |a Kilian, Michael  |d 1990-  |e VerfasserIn  |0 (DE-588)1220319422  |0 (DE-627)1736693255  |4 aut 
700 1 |a Chih, Yu-Chan  |d 1997-  |e VerfasserIn  |0 (DE-588)1317602609  |0 (DE-627)1879494531  |4 aut 
700 1 |a Kourtesakis, Alexandros  |d 1994-  |e VerfasserIn  |0 (DE-588)1323333118  |0 (DE-627)1883337275  |4 aut 
700 1 |a Hoffmann, Dirk C.  |d 1992-  |e VerfasserIn  |0 (DE-588)1231940786  |0 (DE-627)1755605366  |4 aut 
700 1 |a Boschert, Tamara  |d 1997-  |e VerfasserIn  |0 (DE-588)1339408589  |0 (DE-627)1899081259  |4 aut 
700 1 |a Koopmann, Philipp  |e VerfasserIn  |0 (DE-588)1323691863  |0 (DE-627)1883635543  |4 aut 
700 1 |a Sanghvi, Khwab  |e VerfasserIn  |4 aut 
700 1 |a De Roia, Alice  |d 1991-  |e VerfasserIn  |0 (DE-588)127827183X  |0 (DE-627)1831128071  |4 aut 
700 1 |a Jung, Stefanie  |e VerfasserIn  |4 aut 
700 1 |a Jähne, Kristine  |e VerfasserIn  |4 aut 
700 1 |a Day, Bryan  |e VerfasserIn  |4 aut 
700 1 |a Shultz, Lenny D.  |e VerfasserIn  |4 aut 
700 1 |a Ratliff, Miriam  |d 1979-  |e VerfasserIn  |0 (DE-588)1012081028  |0 (DE-627)660894602  |0 (DE-576)344899357  |4 aut 
700 1 |a Harbottle, Richard  |e VerfasserIn  |4 aut 
700 1 |a Green, Edward W.  |e VerfasserIn  |0 (DE-588)1207577499  |0 (DE-627)169408163X  |4 aut 
700 1 |a Will, Rainer  |e VerfasserIn  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Platten, Michael  |d 1971-  |e VerfasserIn  |0 (DE-588)121627780  |0 (DE-627)081431848  |0 (DE-576)261969811  |4 aut 
700 1 |a Bunse, Lukas  |d 1988-  |e VerfasserIn  |0 (DE-588)1051941229  |0 (DE-627)787187399  |0 (DE-576)407600426  |4 aut 
773 0 8 |i Enthalten in  |t Neuro-Oncology  |d Oxford : Oxford Univ. Press, 1999  |g 26(2024), 2 vom: Feb., Seite 266-278  |h Online-Ressource  |w (DE-627)357167341  |w (DE-600)2094060-9  |w (DE-576)318041839  |x 1523-5866  |7 nnas  |a NLGN4X TCR transgenic T cells to treat gliomas 
773 1 8 |g volume:26  |g year:2024  |g number:2  |g month:02  |g pages:266-278  |g extent:13  |a NLGN4X TCR transgenic T cells to treat gliomas 
856 4 0 |u https://doi.org/10.1093/neuonc/noad172  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noad172/7275527  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20240108 
993 |a Article 
994 |a 2024 
998 |g 1051941229  |a Bunse, Lukas  |m 1051941229:Bunse, Lukas  |d 60000  |d 62700  |e 60000PB1051941229  |e 62700PB1051941229  |k 0/60000/  |k 1/60000/62700/  |p 20  |y j 
998 |g 121627780  |a Platten, Michael  |m 121627780:Platten, Michael  |d 60000  |d 62700  |e 60000PP121627780  |e 62700PP121627780  |k 0/60000/  |k 1/60000/62700/  |p 19 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 18 
998 |g 1207577499  |a Green, Edward W.  |m 1207577499:Green, Edward W.  |d 50000  |e 50000PG1207577499  |k 0/50000/  |p 16 
998 |g 1012081028  |a Ratliff, Miriam  |m 1012081028:Ratliff, Miriam  |p 14 
998 |g 127827183X  |a De Roia, Alice  |m 127827183X:De Roia, Alice  |d 60000  |d 62700  |e 60000PD127827183X  |e 62700PD127827183X  |k 0/60000/  |k 1/60000/62700/  |p 9 
998 |g 1323691863  |a Koopmann, Philipp  |m 1323691863:Koopmann, Philipp  |d 60000  |e 60000PK1323691863  |k 0/60000/  |p 7 
998 |g 1339408589  |a Boschert, Tamara  |m 1339408589:Boschert, Tamara  |d 140000  |e 140000PB1339408589  |k 0/140000/  |p 6 
998 |g 1231940786  |a Hoffmann, Dirk C.  |m 1231940786:Hoffmann, Dirk C.  |d 910000  |d 911100  |e 910000PH1231940786  |e 911100PH1231940786  |k 0/910000/  |k 1/910000/911100/  |p 5 
998 |g 1323333118  |a Kourtesakis, Alexandros  |m 1323333118:Kourtesakis, Alexandros  |d 910000  |d 911100  |e 910000PK1323333118  |e 911100PK1323333118  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 1317602609  |a Chih, Yu-Chan  |m 1317602609:Chih, Yu-Chan  |d 140000  |e 140000PC1317602609  |k 0/140000/  |p 3 
998 |g 1220319422  |a Kilian, Michael  |m 1220319422:Kilian, Michael  |d 60000  |d 62700  |e 60000PK1220319422  |e 62700PK1220319422  |k 0/60000/  |k 1/60000/62700/  |p 2 
998 |g 1279191635  |a Krämer, Christopher  |m 1279191635:Krämer, Christopher  |d 60000  |e 60000PK1279191635  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1877432997  |e 4450600428 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Christoper Krämer, Michael Kilian, Yu-Chan Chih, Alexandros Kourtesakis, Dirk C Hoffmann, Tamara Boschert, Philipp Koopmann, Khwab Sanghvi, Alice De Roia, Stefanie Jung, Kristine Jähne, Bryan Day, Lenny D Shultz, Miriam Ratliff, Richard Harbottle, Edward W Green, Rainer Will, Wolfgang Wick, Michael Platten, and Lukas Bunse"]},"id":{"eki":["1877432997"],"doi":["10.1093/neuonc/noad172"]},"physDesc":[{"extent":"13 S."}],"recId":"1877432997","origin":[{"dateIssuedDisp":"February 2024","dateIssuedKey":"2024"}],"person":[{"display":"Krämer, Christopher","role":"aut","given":"Christopher","family":"Krämer"},{"display":"Kilian, Michael","role":"aut","given":"Michael","family":"Kilian"},{"display":"Chih, Yu-Chan","role":"aut","given":"Yu-Chan","family":"Chih"},{"role":"aut","given":"Alexandros","family":"Kourtesakis","display":"Kourtesakis, Alexandros"},{"display":"Hoffmann, Dirk C.","given":"Dirk C.","role":"aut","family":"Hoffmann"},{"given":"Tamara","role":"aut","family":"Boschert","display":"Boschert, Tamara"},{"given":"Philipp","role":"aut","family":"Koopmann","display":"Koopmann, Philipp"},{"family":"Sanghvi","given":"Khwab","role":"aut","display":"Sanghvi, Khwab"},{"display":"De Roia, Alice","family":"De Roia","given":"Alice","role":"aut"},{"display":"Jung, Stefanie","family":"Jung","role":"aut","given":"Stefanie"},{"family":"Jähne","given":"Kristine","role":"aut","display":"Jähne, Kristine"},{"family":"Day","given":"Bryan","role":"aut","display":"Day, Bryan"},{"display":"Shultz, Lenny D.","given":"Lenny D.","role":"aut","family":"Shultz"},{"display":"Ratliff, Miriam","role":"aut","given":"Miriam","family":"Ratliff"},{"role":"aut","given":"Richard","family":"Harbottle","display":"Harbottle, Richard"},{"family":"Green","given":"Edward W.","role":"aut","display":"Green, Edward W."},{"display":"Will, Rainer","family":"Will","role":"aut","given":"Rainer"},{"family":"Wick","role":"aut","given":"Wolfgang","display":"Wick, Wolfgang"},{"family":"Platten","given":"Michael","role":"aut","display":"Platten, Michael"},{"display":"Bunse, Lukas","role":"aut","given":"Lukas","family":"Bunse"}],"relHost":[{"pubHistory":["1.1999 -"],"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisherPlace":"Oxford ; Durham, NC","publisher":"Oxford Univ. Press ; Duke University Medical Center"}],"note":["Gesehen am 21.07.23"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"official journal of the World Federation of Neuro-Oncology","title":"Neuro-Oncology","title_sort":"Neuro-Oncology"}],"part":{"pages":"266-278","text":"26(2024), 2 vom: Feb., Seite 266-278","extent":"13","issue":"2","year":"2024","volume":"26"},"id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"357167341","disp":"NLGN4X TCR transgenic T cells to treat gliomasNeuro-Oncology"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 16. September 2023","Gesehen am 08.01.2024"],"title":[{"title":"NLGN4X TCR transgenic T cells to treat gliomas","title_sort":"NLGN4X TCR transgenic T cells to treat gliomas"}]} 
SRT |a KRAEMERCHRNLGN4XTCRT2024